Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Elderly Patients with Acute Myeloid Leukemia Are Not All the Same: Results of the Prospective DSIL AML96 Trial.

Markus Andreas Schaich, MD, Walter E. Aulitzky, MD, Heinrich Bodenstein, MD, Martin Bornhaeuser, MD, Thomas Illmer, MD, Ulrike Schaekel, MD, Norbert Schmitz, MD, Ulrich S. Schuler, MD, Silke Soucek, Christian Thiede, MD, Hannes Wandt, MD, Gerhard Ehninger, MD

Blood (2007) 110 (11): 1840.

https://doi.org/10.1182/blood.V110.11.1840.1840

Published: 2007

Journal Articles

Cup-Like AML - New Disease or Morphological Phenomenon?.

Frank P. Kroschinsky, MD, Ulrike Schaekel, MD, Rainer Fischer, MD, Markus Andreas Schaich, MD, Silke Soucek, Gustavo Baretton, Gerhard Ehninger, Christian Thiede

Blood (2006) 108 (11): 2357.

https://doi.org/10.1182/blood.V108.11.2357.2357

Published: 2006

Journal Articles

Comparison of Different Techniques for the Detection of FLT3-Mutations in Exons 14/15 and 20 in Patients with Acute Myeloid Leukemia.

Christian Thiede, MD, Jan Heidemann, Markus Andreas Schaich, MD, Thomas Illmer, MD, Gerhard Ehninger, MD

Blood (2006) 108 (11): 2306.

https://doi.org/10.1182/blood.V108.11.2306.2306

Published: 2006

Journal Articles

AF1q Is a Novel Poor Prognostic Marker for Adult Acute Myelogenous Leukemia (AML) Patients with Normal Cytogenetics.

Crawford J. Strunk, MD, Uwe Platzbecker, MD, Christian Thiede, MD, Markus Andreas Schaich, MD, Thomas Illmer, MD, Zizhen Kang, PhD, Patrick Leahy, PhD, Chunbiao Li, Sunee Reiner, Mary J. Laughlin, MD, Hillard M. Lazarus, MD, Kevin D. Bunting, PhD, Stanton L. Gerson, MD, Gerhard Ehninger, MD, William W. Tse, MD

Blood (2005) 106 (11): 3294.

https://doi.org/10.1182/blood.V106.11.3294.3294

Published: 2005

Journal Articles

Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup.

Markus Andreas Schaich, MD, Silke Soucek, Hartmut Döhner, MD, Gerhard Ehninger, MD, Arnold Ganser, MD, Gerhard Heil, MD, Rainer Krahl, MD, Jürgen Krauter, MD, Dietger W. Niederwieser, MD, Christina Sauerland, Thomas Büchner, MD, Richard F. Schlenk, MD

Blood (2005) 106 (11): 2374.

https://doi.org/10.1182/blood.V106.11.2374.2374

Published: 2005

Journal Articles

Rapid Risk-Profiling Including Fast Donor Search within a Multi-Center Trial Allows for Early Allogeneic Stem Cell Transplantation during Aplasia in Patients with High-Risk Acute Myeloid Leukemia.

Markus Andreas Schaich, MD, Monika Fuessel, PhD, Martin Bornhaeuser, MD, Christian Thiede, MD, Brigitte Mohr, PhD, Thomas Illmer, MD, Ulrike Schaekel, MD, Gabriele Prange-Krex, MD, Uta Oelschlaegel, PhD, Gerhard Ehninger, MD, on behalf of the DSIL AML2003 study group

Blood (2004) 104 (11): 2767.

https://doi.org/10.1182/blood.V104.11.2767.2767

Published: 2004

NARROW

Elderly Patients with Acute Myeloid Leukemia Are Not All the Same: Results of the Prospective DSIL AML96 Trial.

Cup-Like AML - New Disease or Morphological Phenomenon?.

Comparison of Different Techniques for the Detection of FLT3-Mutations in Exons 14/15 and 20 in Patients with Acute Myeloid Leukemia.

AF1q Is a Novel Poor Prognostic Marker for Adult Acute Myelogenous Leukemia (AML) Patients with Normal Cytogenetics.

Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup.

Rapid Risk-Profiling Including Fast Donor Search within a Multi-Center Trial Allows for Early Allogeneic Stem Cell Transplantation during Aplasia in Patients with High-Risk Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Elderly Patients with Acute Myeloid Leukemia Are Not All the Same: Results of the Prospective DSIL AML96 Trial.

Cup-Like AML - New Disease or Morphological Phenomenon?.

Comparison of Different Techniques for the Detection of FLT3-Mutations in Exons 14/15 and 20 in Patients with Acute Myeloid Leukemia.

AF1q Is a Novel Poor Prognostic Marker for Adult Acute Myelogenous Leukemia (AML) Patients with Normal Cytogenetics.

Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup.

Rapid Risk-Profiling Including Fast Donor Search within a Multi-Center Trial Allows for Early Allogeneic Stem Cell Transplantation during Aplasia in Patients with High-Risk Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only